Müllerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology

T. Silberstein, D. T. MacLaughlin, I. Shai, J. R. Trimarchi, G. Lambert-Messerlian, David Seifer, D. L. Keefe, A. S. Blazar

Research output: Contribution to journalArticle

144 Citations (Scopus)

Abstract

Background: Pre-antral and early antral follicles secrete Müllerian inhibiting substance (MIS), suggesting that MIS may directly reflect ovarian reserve. Since little is known about how ovarian reserve affects oocyte quality, we attempt here to assess the predictive value of MIS on embryo morphology and IVF outcome. To do so, we measured MIS at the time of HCG administration 36 h prior to oocyte retrieval. Methods: A total of 257 patients undergoing IVF were prospectively recruited. We measured MIS levels by enzyme-linked immunosorbent assay at the time of HCG, and compared the MIS values to day 3 FSH levels in the prediction of embryo morphology and IVF outcome. Results: The distribution of MIS levels was skewed, with a median of 2.7 ng/ml (range 0 to 28.5 ng/ml). MIS values at the time of HCG administration inversely correlated with basal FSH levels (P = 0.002), and both correlated significantly with patient age, number of mature follicles, number of oocytes retrieved and serum estradiol levels. MIS levels correlated significantly with a greater number of 6-cell embryos and better embryo morphology score, while basal FSH levels did not correlate with these outcome variables. MIS levels > 2.7 ng/ml portended improved oocyte quality as reflected in a higher implantation rate (P = 0.001) and a trend toward a better clinical pregnancy rate (P = 0.084). Conclusions: MIS levels seem to predict not only ovarian reserve, but also embryo morphology. Measurement of MIS at the time of HCG administration may, therefore, in the future improve management of patients undergoing treatments with assisted reproductive technology.

Original languageEnglish (US)
Pages (from-to)159-163
Number of pages5
JournalHuman Reproduction
Volume21
Issue number1
DOIs
StatePublished - Jan 2006
Externally publishedYes

Fingerprint

Embryonic Structures
Oocytes
Oocyte Retrieval
Assisted Reproductive Techniques
Pregnancy Rate
Estradiol
Cell Count
Enzyme-Linked Immunosorbent Assay
Ovarian Reserve
Serum
Antral
Therapeutics

Keywords

  • Embryo morphology
  • IVF
  • Müllerian inhibiting substance
  • Ovarian reserve
  • Pregnancy rate

ASJC Scopus subject areas

  • Physiology
  • Developmental Biology
  • Obstetrics and Gynecology
  • Reproductive Medicine

Cite this

Silberstein, T., MacLaughlin, D. T., Shai, I., Trimarchi, J. R., Lambert-Messerlian, G., Seifer, D., ... Blazar, A. S. (2006). Müllerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology. Human Reproduction, 21(1), 159-163. https://doi.org/10.1093/humrep/dei270

Müllerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology. / Silberstein, T.; MacLaughlin, D. T.; Shai, I.; Trimarchi, J. R.; Lambert-Messerlian, G.; Seifer, David; Keefe, D. L.; Blazar, A. S.

In: Human Reproduction, Vol. 21, No. 1, 01.2006, p. 159-163.

Research output: Contribution to journalArticle

Silberstein, T, MacLaughlin, DT, Shai, I, Trimarchi, JR, Lambert-Messerlian, G, Seifer, D, Keefe, DL & Blazar, AS 2006, 'Müllerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology', Human Reproduction, vol. 21, no. 1, pp. 159-163. https://doi.org/10.1093/humrep/dei270
Silberstein, T. ; MacLaughlin, D. T. ; Shai, I. ; Trimarchi, J. R. ; Lambert-Messerlian, G. ; Seifer, David ; Keefe, D. L. ; Blazar, A. S. / Müllerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology. In: Human Reproduction. 2006 ; Vol. 21, No. 1. pp. 159-163.
@article{6c0f5c1a5d1e4a27bc7d37471f50c8b4,
title = "M{\"u}llerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology",
abstract = "Background: Pre-antral and early antral follicles secrete M{\"u}llerian inhibiting substance (MIS), suggesting that MIS may directly reflect ovarian reserve. Since little is known about how ovarian reserve affects oocyte quality, we attempt here to assess the predictive value of MIS on embryo morphology and IVF outcome. To do so, we measured MIS at the time of HCG administration 36 h prior to oocyte retrieval. Methods: A total of 257 patients undergoing IVF were prospectively recruited. We measured MIS levels by enzyme-linked immunosorbent assay at the time of HCG, and compared the MIS values to day 3 FSH levels in the prediction of embryo morphology and IVF outcome. Results: The distribution of MIS levels was skewed, with a median of 2.7 ng/ml (range 0 to 28.5 ng/ml). MIS values at the time of HCG administration inversely correlated with basal FSH levels (P = 0.002), and both correlated significantly with patient age, number of mature follicles, number of oocytes retrieved and serum estradiol levels. MIS levels correlated significantly with a greater number of 6-cell embryos and better embryo morphology score, while basal FSH levels did not correlate with these outcome variables. MIS levels > 2.7 ng/ml portended improved oocyte quality as reflected in a higher implantation rate (P = 0.001) and a trend toward a better clinical pregnancy rate (P = 0.084). Conclusions: MIS levels seem to predict not only ovarian reserve, but also embryo morphology. Measurement of MIS at the time of HCG administration may, therefore, in the future improve management of patients undergoing treatments with assisted reproductive technology.",
keywords = "Embryo morphology, IVF, M{\"u}llerian inhibiting substance, Ovarian reserve, Pregnancy rate",
author = "T. Silberstein and MacLaughlin, {D. T.} and I. Shai and Trimarchi, {J. R.} and G. Lambert-Messerlian and David Seifer and Keefe, {D. L.} and Blazar, {A. S.}",
year = "2006",
month = "1",
doi = "10.1093/humrep/dei270",
language = "English (US)",
volume = "21",
pages = "159--163",
journal = "Human Reproduction",
issn = "0268-1161",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Müllerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology

AU - Silberstein, T.

AU - MacLaughlin, D. T.

AU - Shai, I.

AU - Trimarchi, J. R.

AU - Lambert-Messerlian, G.

AU - Seifer, David

AU - Keefe, D. L.

AU - Blazar, A. S.

PY - 2006/1

Y1 - 2006/1

N2 - Background: Pre-antral and early antral follicles secrete Müllerian inhibiting substance (MIS), suggesting that MIS may directly reflect ovarian reserve. Since little is known about how ovarian reserve affects oocyte quality, we attempt here to assess the predictive value of MIS on embryo morphology and IVF outcome. To do so, we measured MIS at the time of HCG administration 36 h prior to oocyte retrieval. Methods: A total of 257 patients undergoing IVF were prospectively recruited. We measured MIS levels by enzyme-linked immunosorbent assay at the time of HCG, and compared the MIS values to day 3 FSH levels in the prediction of embryo morphology and IVF outcome. Results: The distribution of MIS levels was skewed, with a median of 2.7 ng/ml (range 0 to 28.5 ng/ml). MIS values at the time of HCG administration inversely correlated with basal FSH levels (P = 0.002), and both correlated significantly with patient age, number of mature follicles, number of oocytes retrieved and serum estradiol levels. MIS levels correlated significantly with a greater number of 6-cell embryos and better embryo morphology score, while basal FSH levels did not correlate with these outcome variables. MIS levels > 2.7 ng/ml portended improved oocyte quality as reflected in a higher implantation rate (P = 0.001) and a trend toward a better clinical pregnancy rate (P = 0.084). Conclusions: MIS levels seem to predict not only ovarian reserve, but also embryo morphology. Measurement of MIS at the time of HCG administration may, therefore, in the future improve management of patients undergoing treatments with assisted reproductive technology.

AB - Background: Pre-antral and early antral follicles secrete Müllerian inhibiting substance (MIS), suggesting that MIS may directly reflect ovarian reserve. Since little is known about how ovarian reserve affects oocyte quality, we attempt here to assess the predictive value of MIS on embryo morphology and IVF outcome. To do so, we measured MIS at the time of HCG administration 36 h prior to oocyte retrieval. Methods: A total of 257 patients undergoing IVF were prospectively recruited. We measured MIS levels by enzyme-linked immunosorbent assay at the time of HCG, and compared the MIS values to day 3 FSH levels in the prediction of embryo morphology and IVF outcome. Results: The distribution of MIS levels was skewed, with a median of 2.7 ng/ml (range 0 to 28.5 ng/ml). MIS values at the time of HCG administration inversely correlated with basal FSH levels (P = 0.002), and both correlated significantly with patient age, number of mature follicles, number of oocytes retrieved and serum estradiol levels. MIS levels correlated significantly with a greater number of 6-cell embryos and better embryo morphology score, while basal FSH levels did not correlate with these outcome variables. MIS levels > 2.7 ng/ml portended improved oocyte quality as reflected in a higher implantation rate (P = 0.001) and a trend toward a better clinical pregnancy rate (P = 0.084). Conclusions: MIS levels seem to predict not only ovarian reserve, but also embryo morphology. Measurement of MIS at the time of HCG administration may, therefore, in the future improve management of patients undergoing treatments with assisted reproductive technology.

KW - Embryo morphology

KW - IVF

KW - Müllerian inhibiting substance

KW - Ovarian reserve

KW - Pregnancy rate

UR - http://www.scopus.com/inward/record.url?scp=29144452458&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29144452458&partnerID=8YFLogxK

U2 - 10.1093/humrep/dei270

DO - 10.1093/humrep/dei270

M3 - Article

C2 - 16123085

AN - SCOPUS:29144452458

VL - 21

SP - 159

EP - 163

JO - Human Reproduction

JF - Human Reproduction

SN - 0268-1161

IS - 1

ER -